OUTLAW LAB
The Outlaw Lab will use chemical and biophysical tools to study important problems in human health and medicine. Our interdisciplinary group will develop new synthetic strategies, elucidate biomacromolecular structure, and identify mechanisms underlying infectious disease. We are excited for the opportunity to translate the discoveries made by our lab into innovations that have the potential to significantly improve human health and well-being.
NEWS
June 2024
Congrats to Hamza for being awarded the Mizzou Black Alumni Network Scholarship.
January 2024
Congrats to Hamza and Kellen for their manuscript, “A Synthetic Route to Highly Substituted 1-Aminonaphthalenes from Readily Available Benzaldehydes,” being accepted in JOC!
January 2024
The Outlaw Lab welcomes graduate student Omar Essam to the group.
September 2023
The lab welcomes undergraduates Carson Wooster and Tyler Kieffner to the group.
May 2023
Congrats to Kellen for being awarded a Mizzou Forward Undergraduate Research Fellowship.
March 2023
Graduate student Hassan Seyrani joins the group. Welcome to the Outlaw Lab!
December 2022
The Outlaw Lab welcomes graduate student Hossein Heidarzadeh to the group.
September 2022
The lab welcomes undergraduates Eve Sugg and Matthew Austell to the group.
July 2022
Congrats to Hamza for being named as part of the 2022–2023 Graduate Scholars of Excellence program.
June 2022
Congrats to Victor for being named as part of the 2022 University of Missouri Early Career Research Development Fellows program.
May 2022
Congrats to Jiani and the Gellman lab for their publication “Trimer-to-Monomer Disruption Mechanism for a Potent, Protease-Resistant Antagonist of Tumor Necrosis Factor-α Signaling” in JACS.
December 2021
The Outlaw Lab welcomes its inaugural class of graduate students, Rifat Apurba, Hamza Ozomarisi, and Nisansala Vithanage.
September 2021
The Outlaw Lab welcomes its first students, undergraduates Kellen Sharpe and Carson Bair.
June 2021
Congrats to Cyrille and the Moscona and Porotto labs for their publication “Molecular Features of the Measles Virus Viral Fusion Complex That Favor Infection and Spread in the Brain” in mBio.
April 2021
Victor’s manuscript “Engineering protease-resistant peptides to inhibit human parainfluenza viral respiratory infection” was published in JACS and selected for a JACS Spotlight.
February 2021
Victor’s manuscript “Engineering protease-resistant peptides to inhibit human parainfluenza viral respiratory infection” was uploaded to BioRxiv.
December 2020
Victor’s work on the development of SARS-CoV-2 fusion inhibitors was highlighted in Badger Chemist News.
October 2020
Victor’s mBio paper “Inhibition of Coronavirus Entry In Vitro and Ex Vivo by a Lipid-Conjugated Peptide Derived from the SARS-CoV-2 Spike Glycoprotein HRC Domain” was selected as an Editor’s Pick.
September 2020
Victor’s paper “Inhibition of Coronavirus Entry In Vitro and Ex Vivo by a Lipid-Conjugated Peptide Derived from the SARS-CoV-2 Spike Glycoprotein HRC Domain” was published in mBio.
July 2020
Victor’s paper “Effects of Single α-to-β Residue Replacements on Recognition of an Extended Segment in a Viral Fusion Protein” was published in ACS Infectious Diseases.
April 2020
Victor accepts a position as Assistant Professor in the Department of Chemistry at the University of Missouri starting August 2021. If you are interested in joining the Outlaw Lab, see the Members page for more information.